brexit

Showing 15 posts of 137 posts found.

top_10_image

Top Ten most popular articles on Pharmafile.com this week!

November 23, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Kymriah, Mundipharma, UK, US, brexit, pharma, politics, top 10

The appointment of GSK veteran Arnaud Breabout to the position of Senior Vice President and CFO of Mundipharma took the …

ian_hudson

MHRA Chief to step down in 2019

November 21, 2018
Medical Communications, Research and Development MHRA, UK, brexit, pharma

The Medicines and Healthcare products Regulatory Agency (MHRA), the regulator responsible for the efficacy and safety of medicines in the …

top_10_image

Top Ten most popular articles on Pharmafile.com this week!

November 16, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Korea, NICE, Samsung, Theresa May, UK, brexit, politics, top 10

The Samsung scandal played a prominent role in this weeks’ top ten after the South Korean firm was delisted from …

4768764591_9e4f7f0eb8_z

Phamaceutical trade lobby responds to Brexit deal

November 15, 2018
Business Services, Medical Communications, Research and Development ABPI, brexit, negotiations, pharma, politics

The Association of the British Pharmaceutical Industry (ABPI) has responded to Theresa May’s Brexit deal, after the government announced a …

28246711066_52e38bc591_z

No-deal Brexit preparations are a waste of time and money, according to Welsh industry representatives

November 12, 2018
Sales and Marketing ABPI, brexit, no-deal, pharma, stockpiling

The UK government’s request that pharmaceutical companies stockpile an additional six weeks’ worth of medicine, in preparation for a no-deal …

top_10_image

Top Ten most popular articles on Pharmafile.com this week!

October 26, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, GSK, HDA, J&J, JJ, brexit, clinical trials, pharmafile, resutls, stockpiling, top 10

Winter is coming! And with it an assortment of promising and not so promising results from big pharma. While J&J …

28246711066_52e38bc591_z

Industry leaders warn public may have to stockpile medicines in case of no-deal Brexit

October 24, 2018
Research and Development brexit, no-deal Brexit, stockpiling

Martin Sawer, the executive director of the Healthcare Distribution Association (HDA) – formerly the British Association of Pharmaceutical Wholesalers (BAPW) …

top_10_image

Top Ten most popular articles on Pharmafile.com this week

October 19, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, AstraZeneca, Bayer, Novartis, Samsung, Trump, biosimilars, brexit

Business, biosimilars and Brexit are the themes of this week’s top 10. While Roche signed a $1 billion deal with …

astrazeneca_plaque

AstraZeneca halting UK investment due to Brexit uncertainty

October 15, 2018
Manufacturing and Production AstraZeneca, Le Monde, UK, brexit, no-deal

The Anglo-Swedish pharma firm AstraZeneca has suspended investment into the United Kingdom, due to the uncertainty surrounding Brexit. The firm’s …

european_commission_web_5

MHRA to consult on potential for no-deal Brexit

October 5, 2018
Medical Communications EU, MHRA, brexit, uk politics

The Medicines and Healthcare products Regulatory Agency (MHRA) has opened a consultation on how its legislation and regulatory processes would …

Survey reveals 56% gender pay gap between doctors in NHS

October 4, 2018
Medical Communications NHS, UK, brexit, doctors, pay gap

Male doctors in the United Kingdom earn 56% more than their female counterparts, according to a survey conducted by Medscape. …

4768764591_9e4f7f0eb8_z

Clinical trial halted because of Brexit, UK Government downplays concerns

October 3, 2018
Research and Development UK, brexit, clinical trials, politics, research

A clinical trial looking into the safety and efficacy of the drug dutogliptin has been halted due to uncertainties surrounding …

28246711066_52e38bc591_z

EMA says pharma industry now more prepared for Brexit

September 27, 2018
Manufacturing and Production, Medical Communications EMA, EU, brexit, products, qppv

In July of this year the European Medicines Agency (EMA) identified significant gaps in the pharmaceutical industry’s preparedness for Brexit. …

top_10_image

Top Ten most popular articles on Pharmafile.com this week

September 14, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bristol-Myers Squibb, FDA, NICE, Novo Nordisk, Spinraza, brexit, bristol myers squibb, top 10

With the Pharmafocus team having avoided hurricane Florence and finally arriving back in the UK just last night, after stopping …

Latest content